The Milken Institute and Ann Theodore Foundation have awarded $600,000 in funding to early-career sarcoidosis researchers through the Learning Opportunities in Medicine and Sarcoidosis grant program. The program aims to provide sustainable funding and mentorship to rising generations of researchers and clinicians.
The Milken Institute and Ann Theodore Foundation have launched a new funding program, ATF-SIM, to support a Phase 2 clinical trial assessing the effectiveness of mTOR inhibitors in treating cutaneous sarcoidosis. The grant will award up to $575,000 to researchers to design and conduct the trial.
The BD² Discovery Research program awards $18 million to researchers exploring the neural circuitry of bipolar disorder. This funding enables the development of innovative treatment approaches and accelerates better care for those living with the condition.
The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative has awarded over $2.5 million to interdisciplinary research teams to study sarcoidosis, a debilitating inflammatory condition. The funding aims to advance understanding of the disease's underlying biology and develop novel therapeutics.
The Kissick Family Foundation has awarded four two-year grants to researchers to advance scientific understanding of frontotemporal dementia. The program will continue to build a fundamental understanding of sporadic FTD, with the goal of identifying potential treatments and improving patient outcomes.
Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²) has announced a fourth round of Discovery Research funding for bipolar disorder. The program aims to support groundbreaking research into the genetic, molecular, cellular, circuit, and behavioral mechanisms of the disorder.
The BD² Integrated Network, a collaborative research model, aims to improve care and outcomes for people with bipolar disorder. The Ottawa Hospital Research Institute will receive $2.3 million to join the network, accelerating recruitment and advancing discovery.
The BD² Integrated Network, a collaborative model connecting bipolar disorder research and care, has expanded to 10 sites with four new institutions joining the network. The model combines traditional longitudinal cohort study and learning health network to improve outcomes for people with bipolar disorder.
The Milken Institute has released a roadmap to increase autoantibody screening for Type 1 Diabetes, with the support of The Leona M. and Harry B. Helmsley Charitable Trust. The goal is to ensure effective screening, which can diagnose T1D early, prevent life-threatening conditions like diabetic ketoacidosis, and develop therapeutics.
The Baszucki Brain Research Fund has launched a multimillion-dollar program to advance therapeutic discovery for bipolar disorder, aiming to improve treatment options for affected individuals. The grant program will provide up to $200,000 per year to support pilot research and translational efforts.
The Misophonia Research Fund has awarded over $4 million in funding to researchers studying misophonia, a condition that triggers strong emotions in response to specific sounds. The funded projects will develop new therapeutic strategies and investigate the physiological basis of misophonia symptomology.
The number of Americans living with Alzheimer's disease or other dementias is projected to nearly double to nearly 13 million over the next 20 years. Women will shoulder more than 80 percent of the cumulative costs, with 4.7 million women expected to have dementia by 2020.
Massachusetts ranked No. 1 in the Milken Institute's 2018 State Technology and Science Index, driven by major research universities and a tech-oriented workforce. Utah rose to fifth place with rapid employment growth in technology and science, while Delaware strengthened its position with venture capital investment.
The economic impact of obesity and excess weight in the US has reached $1.7 trillion, according to a new study by the Milken Institute. Direct health-care costs total $480.7 billion, while lost productivity adds another $1.24 trillion.